Non-statin cholesterol drugs on HealthSpring Assurance Rx (S5617-348)
Ezetimibe, the PCSK9 drugs Repatha and Praluent, and Nexletol, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), Puerto Rico
- Premium
- $65.70/month
- Deductible
- $615.00
5 of 8 Non-statin cholesterol drugs are covered on this plan. 2 of them require prior authorization.
3 aren't on the formulary, including Praluent and Nexlizet.
- $2.00Tier 2
- from $357.04Tier 3
- $90.77Tier 3
- $2.00Tier 2
- 34%Tier 4
Not on the formulary
Praluent, Nexlizet, Vascepa
Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.